Angiosomes applications in critical limb ischemia

The angiosome principle was first described by Jan Taylor in 1987 in the plastic reconstructive surgery field, providing useful information on the vascular anatomy of the human body. Particularly concerning foot and ankle ischemic pathology, it may help the clinician to better select revascularization strategies for specific territories that exhibit tissue loss.
Although without confirmed clinical evidence at the present time, this knowledge may be surprisingly beneficial when treating diabetic or renal patients with ischemic foot wounds in peculiar regions that associate poor collateral compensatory circulation.
The present volume has a difficult task to fulfil; it gathers recent clinical data regarding new applications, results and perspectives of this new concept, in a field that still remains controversial.
The implementation of angiosome-based strategies in infragenicular CL I treatment may afford encouraging wound healing and limb preservation rates by using both bypass and endovascular techniques; however, further clinical experience in multicentric and prospective trials will be needed to ascertain this novel theory.
Contents
The angiosome concept: anatomical background and physiopathological landmarks in CLI
Clinical endpoints following the angiosome model of reperfusion
Angiosome specific diagnosis of the ischemic foot
Particularities in wound healing in diabetic neuro-ischemic foot wounds: why the angiosome model may be useful?
The role of individual collateral reserve in tissue healing for angiosome-oriented revascularization
New endovascular approaches and their benefit in topographic CLI revascularization
Potential applications and advantages of endovascular strategies in angiosome-guided revascularization
What do we know about the angiosomes usefulness in current CLI treatment?
Importance of multidisciplinary surveillance after topographic arterial treatment for limb salvage